Managing Canine Hypothyroidism

Hypothyroidism is the most common endocrine disorder in dogs. Treatment of hypothyroidism is more likely to succeed if the pet owner complies with medication dosing regimens and formulations. A recent market research study¹ of veterinarians revealed a high level of concern about client compliance with inconvenient medication dosing regimens and formulations. The majority of veterinarians — 58 percent — cited frequency of administration as the most significant barrier to client compliance.

We developed Leventa® with the aim of helping veterinarians meet the needs of clients who want options — especially when administering medications for chronic conditions. Leventa is a readily accepted, easily administered, small-volume liquid formulation of levothyroxine sodium.

A recent market research study of dog owners found compelling evidence of a need for a liquid canine hypothyroidism medication. Key findings include

90 percent want their veterinarians to offer treatment formulation options.¹
More than 75 percent prefer a small-volume liquid given once a day.¹
84 percent prefer a readily accepted, once-daily liquid over a twice-daily, traditional oral tablet.¹
83 percent say they would be more successful if they could administer medication only once a day.¹

¹ Proprietary market research data on file; Intervet Inc.

Leventa’s liquid formulation facilitates precise dosing and flexibility. All this adds up to optimal client compliance and positive treatment outcomes.

Intervet understands that your time is precious and that dog owners will require information and support. This web site is intended to help you and your client de-dramatize the disease and educate your clients about hypothyroidism. If you don't find in these pages the resources or information on Leventa that you are looking for, please contact our technical services specialists at 877-783-4840; we will gladly help you.

Important Safety Information.
Leventa is contraindicated in dogs with thyrotoxicosis, acute myocardial infarction and uncorrected adrenal insufficiency. Use in pregnant bitches has not been evaluated. Overdosage can result in thyrotoxicosis. Administer with caution to animals with clinically significant heart disease, hypertension or other complications for which a sharply increased metabolic rate might prove hazardous. Please refer to the package insert for complete product information